Patent · US Active

Sulcardine administration for treatment of acute atrial fibrillation

US12357611B2 · kind B2 · utility

0Cited by
6References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 19, 2023
Grant dateJul 15, 2025
Priority date—
Expiry dateDec 19, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compositions and methods for administration of sulcardine to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.